CI U.S. Stock Selection Private Pool

Series A CAD
 

Fund overview

The pool’s investment objective is to provide long-term capital growth by investing primarily in large-cap U.S. equity and equity-related securities. Any change to the fundamental investment objective must be approved by a majority of votes cast at a meeting of securityholders held for that reason.

Fund details

description of elementelement value
Inception date August 2025
CAD Total net assets ($CAD)
As at 2026-02-27
$1.0 million
NAVPS
As at 2026-03-20
$9.4778
MER (%)
As at 2025-09-30
2.03
Management fee (%) 1.65
Asset class U.S. Equity
Currency CAD
Minimum investment $5,000 initial/$25 additional

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

A 2034
F 4034
I 5034

Performance2 As at 2026-02-28

*Fund performance is not available for funds with a history of less than one year.

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Jeremy Rosa
Peter Hofstra

CI U.S. Stock Selection Private Pool

Series A CAD
 
Portfolio allocations3 As at 2026-02-28
Asset allocation (%)
  • US Equity 86.91
  • International Equity 8.68
  • Canadian Equity 2.60
  • Cash and Equivalents 1.83
  • Other -0.02
Sector allocation (%)
  • Technology 50.07
  • Healthcare 30.27
  • Financial Services 8.44
  • Consumer Services 7.78
  • Cash and Cash Equivalent 1.83
  • Energy 1.63
  • Other -0.02
Geographic allocation(%)
  • United States 86.91
  • Canada 4.43
  • United Kingdom 3.08
  • Taiwan 2.45
  • Netherlands 1.89
  • Cayman Islands 1.26
  • Other -0.02
Top holdings4
Sector (%)
1. NVIDIA Corp Computer Electronics 9.32%
2. Alphabet Inc Cl C Information Technology 7.28%
3. Microsoft Corp Information Technology 7.18%
4. Amazon.com Inc Retail 5.40%
5. Boston Scientific Corp Healthcare Equipment 4.66%
6. Eli Lilly and Co Drugs 4.26%
7. Meta Platforms Inc Cl A Information Technology 4.23%
8. Broadcom Inc Computer Electronics 4.00%
9. Thermo Fisher Scientific Inc Healthcare Equipment 3.54%
10. DexCom Inc Healthcare Equipment 3.37%
11. Apple Inc Computer Electronics 3.21%
12. Mastercard Inc Cl A Diversified Financial Services 3.17%
13. Merck & Co Inc Drugs 3.09%
14. AstraZeneca PLC Drugs 3.08%
15. AbbVie Inc Drugs 3.06%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.